May 3, Episode 6: 'Individualized Cancer Vaccines’
Some vaccines prevent cancer, while other vaccines treat cancer. In this episode, Cathy Wurzer, a broadcast journalist from Minnesota Public Radio, talks with two noted experts in immunology. Listen as they discuss the differences between the two vaccines, the excitement and challenges in the precision oncology world on how to design vaccines for individual cancer types, the importance of clinical trials, and advances in immunotherapy.
“Over the next 20-30 years we’re going to see some really striking advances in terms of how we identify what’s foreign on the tumor and how do we get that into the clinic very rapidly. It’s a very exciting time for treating cancer using vaccines.” - Dr. Knutson
“Coronavirus has totally changed the speed of the process. We’ve gone from being able to develop new therapeutics to actually being able to build them and implement them and put them into clinical studies at a much faster rate. We’ve learned a lot about how to monitor vaccines, how to drive additional immune responses, to try to get vaccines like RNA to work a lot stronger. In the cancer field we’re going to benefit from a lot of that knowledge.” - Dr. Anderson
Look for this upcoming episode
May 17: 3D Tissue Models in Health Care
Jonathan Morris, M.D., Associate Professor of Radiology, Mayo Clinic College of Medicine and Science
Peter Liacouras, Ph.D., Director of Services for the 3D Medical Application Center, Walter Reed National Military Medical Center
Read more stories about advances in individualized medicine.
Register for weekly updates from the Mayo Clinic Center for Individualized Medicine blog.